www.nineoclock.ro:
BIOFARM records a net profit of 77 million lei in 2023, up 9% compared to 2022
“In 2023, we successfully implemented cost optimization strategies, focusing in particular on two of our company values: performance and end-consumer care. In doing so, we were able to identify effective ways to control our expenses, even in the context of rising raw material and packaging prices. The Consumer Healthcare category in Romania is becoming more and more competitive year by year, marked also by a slight decline in volumes in 2023 compared to 2022. However, we ended 2023 managing to consolidate our position on the market, with a positive evolution of the volume market share and to contribute positively on the quality of life of patients and consumers in Romania“, said Catalin Vicol, BIOFARM CEO.
The company dominates in value in 6 key categories across brands: #Bixtonim, #Triferment, #Colebil, #Extravalerianic, #Carmol and #Carbocit. In addition, #Biofarm is the volume leader in no less than 8 categories, highlighting the outstanding performance of the brands #Bixtonim, #Colebil, #Triferment, #Sennalax, #Extravalerianic, #Carmol, #Carbocit and #Nervocalmin.
#NineOClockDailyNews #LatestNews #NewsRoundup #FinancialIntegrity #RomaniaNews #SocialMediaUpdates #Facebook #LinkedIn #YouTube #subscribenow #Romania #News #economynews #economy
https://lnkd.in/dY7rznD7
